2021 Volume 65 Issue 1 Pages 17-19
Cytomegalovirus (CMV) colitis associated with chemotherapy for gynecologic cancer is rare. We report a case of CMV colitis linked to treatment with paclitaxel/carboplatin (TC) and bevacizumab (BEV) for ovarian cancer. Our patient was a 59-year-old woman who completed one course of TC chemotherapy and one course of TC + BEV as neoadjuvant chemotherapy for advanced ovarian cancer. On the 7th day of TC + BEV therapy, she visited our hospital for continuous diarrhea, abdominal pain, and melena. Grade 4 neutropenia and fever were also detected. She was diagnosed as CMV colitis via colonoscopy and histopathological examination. This is the first case report of CMV colitis complicated by chemotherapy-induced febrile neutropenia during the treatment for gynecologic cancer.
